Magadan boosts 2026 healthcare budget to 11.8 billion rubles amid rising costs
Magadan boosts 2026 healthcare budget to 11.8 billion rubles amid rising costs
Magadan boosts 2026 healthcare budget to 11.8 billion rubles amid rising costs
The Magadan Regional Duma has approved an increased budget for the 2026 Magadan Regional Compulsory Medical Insurance Fund. The new plan projects higher spending and revenue, aiming to enhance healthcare services for the region’s residents. The 2026 budget sets expenditures at 11.8 billion rubles, an increase of 544 million rubles from the previous year. Revenue has also risen by 21.5 million rubles, reaching 11.3 billion rubles. Despite these changes, a deficit of 522.6 million rubles is expected, to be covered by unused funds from 2025.
The additional funds will support medical institutions, cover administrative expenses, pay for external treatments, and finance more X-ray examinations. The Fund’s normalized insurance reserve has also grown by 59.2 million rubles. Andrey Zykov, first deputy chairman of the Duma, highlighted the positive trend of rising revenue in the Fund’s budget. The budget remains secure and manageable despite the projected shortfall. The extra revenue will help stabilise funding for healthcare providers, improve diagnostic services, and ensure timely external treatment. The goal is to boost the quality of medical care and the well-being of people in Kolyma.
German nursing care reform faces delay as DAK-Gesundheit demands major revisions
A last-minute plea to halt the reform exposes deep flaws in Germany's care system. Will the government rewrite the rules—or risk financial chaos for families and towns?
Region's healthcare transformation brings new hospitals and cutting-edge upgrades
From rural clinics to urban polyclinics, this region's healthcare overhaul is setting new standards. Discover how 149 new facilities and global-trained doctors are reshaping patient care.
FDA's peptide safety review sparks conflict-of-interest concerns this July
From muscle growth to anti-aging, peptides promise miracles—but can the FDA's review be trusted with insiders profiting from the same drugs? A deep dive into the controversy.
Debt repayments now outpace healthcare spending in poorer nations
Kenya spends 29% of revenue on debt—three times its healthcare budget. The IMF's austerity push deepens inequality and strains public services.